vs
Side-by-side financial comparison of EPAM Systems (EPAM) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
BeOne Medicines Ltd. is the larger business by last-quarter revenue ($1.5B vs $1.4B, roughly 1.1× EPAM Systems). EPAM Systems runs the higher net margin — 7.8% vs 4.4%, a 3.3% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 12.8%). BeOne Medicines Ltd. produced more free cash flow last quarter ($379.8M vs $268.1M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 9.9%).
EPAM Systems, Inc. is an American company that specializes in software engineering services, digital platform engineering, and digital product design, operating out of Newtown, Pennsylvania. EPAM is a founding member of the MACH Alliance.
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
EPAM vs ONC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.4B | $1.5B |
| Net Profit | $109.4M | $66.5M |
| Gross Margin | 30.1% | 90.5% |
| Operating Margin | 10.6% | 12.4% |
| Net Margin | 7.8% | 4.4% |
| Revenue YoY | 12.8% | 32.8% |
| Net Profit YoY | 5.9% | 143.8% |
| EPS (diluted) | $1.97 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.4B | $1.5B | ||
| Q3 25 | $1.4B | $1.4B | ||
| Q2 25 | $1.4B | $1.3B | ||
| Q1 25 | $1.3B | $1.1B | ||
| Q4 24 | $1.2B | $1.1B | ||
| Q3 24 | $1.2B | $1.0B | ||
| Q2 24 | $1.1B | $929.2M | ||
| Q1 24 | $1.2B | $751.7M |
| Q4 25 | $109.4M | $66.5M | ||
| Q3 25 | $106.8M | $124.8M | ||
| Q2 25 | $88.0M | $94.3M | ||
| Q1 25 | $73.5M | $1.3M | ||
| Q4 24 | $103.3M | $-151.9M | ||
| Q3 24 | $136.3M | $-121.3M | ||
| Q2 24 | $98.6M | $-120.4M | ||
| Q1 24 | $116.2M | $-251.2M |
| Q4 25 | 30.1% | 90.5% | ||
| Q3 25 | 29.5% | 86.1% | ||
| Q2 25 | 28.8% | 87.5% | ||
| Q1 25 | 26.9% | 85.2% | ||
| Q4 24 | 30.4% | 85.8% | ||
| Q3 24 | 34.6% | 83.0% | ||
| Q2 24 | 29.3% | 85.1% | ||
| Q1 24 | 28.4% | 83.4% |
| Q4 25 | 10.6% | 12.4% | ||
| Q3 25 | 10.4% | 11.5% | ||
| Q2 25 | 9.3% | 6.7% | ||
| Q1 25 | 7.6% | 1.0% | ||
| Q4 24 | 10.9% | -7.0% | ||
| Q3 24 | 15.2% | -12.0% | ||
| Q2 24 | 10.5% | -11.5% | ||
| Q1 24 | 9.5% | -34.8% |
| Q4 25 | 7.8% | 4.4% | ||
| Q3 25 | 7.7% | 8.8% | ||
| Q2 25 | 6.5% | 7.2% | ||
| Q1 25 | 5.6% | 0.1% | ||
| Q4 24 | 8.3% | -13.5% | ||
| Q3 24 | 11.7% | -12.1% | ||
| Q2 24 | 8.6% | -13.0% | ||
| Q1 24 | 10.0% | -33.4% |
| Q4 25 | $1.97 | $0.05 | ||
| Q3 25 | $1.91 | $0.08 | ||
| Q2 25 | $1.56 | $0.06 | ||
| Q1 25 | $1.28 | $0.00 | ||
| Q4 24 | $1.80 | $-0.10 | ||
| Q3 24 | $2.37 | $-0.09 | ||
| Q2 24 | $1.70 | $-0.09 | ||
| Q1 24 | $1.97 | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.3B | $4.5B |
| Total DebtLower is stronger | — | $836.4M |
| Stockholders' EquityBook value | $3.7B | $4.4B |
| Total Assets | $4.9B | $8.2B |
| Debt / EquityLower = less leverage | — | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.3B | $4.5B | ||
| Q3 25 | $1.2B | $4.0B | ||
| Q2 25 | $1.0B | $2.8B | ||
| Q1 25 | $1.2B | $2.5B | ||
| Q4 24 | $1.3B | $2.6B | ||
| Q3 24 | $2.1B | $2.7B | ||
| Q2 24 | $1.8B | $2.6B | ||
| Q1 24 | $2.0B | $2.8B |
| Q4 25 | — | $836.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $3.7B | $4.4B | ||
| Q3 25 | $3.7B | $4.1B | ||
| Q2 25 | $3.7B | $3.8B | ||
| Q1 25 | $3.6B | $3.5B | ||
| Q4 24 | $3.6B | $3.3B | ||
| Q3 24 | $3.6B | $3.4B | ||
| Q2 24 | $3.4B | $3.4B | ||
| Q1 24 | $3.5B | $3.4B |
| Q4 25 | $4.9B | $8.2B | ||
| Q3 25 | $4.8B | $7.6B | ||
| Q2 25 | $4.7B | $6.3B | ||
| Q1 25 | $4.7B | $5.8B | ||
| Q4 24 | $4.8B | $5.9B | ||
| Q3 24 | $4.5B | $5.8B | ||
| Q2 24 | $4.2B | $5.7B | ||
| Q1 24 | $4.4B | $5.7B |
| Q4 25 | — | 0.19× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $282.9M | $417.3M |
| Free Cash FlowOCF − Capex | $268.1M | $379.8M |
| FCF MarginFCF / Revenue | 19.0% | 25.4% |
| Capex IntensityCapex / Revenue | 1.1% | 2.5% |
| Cash ConversionOCF / Net Profit | 2.59× | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | $612.7M | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $282.9M | $417.3M | ||
| Q3 25 | $294.7M | $402.6M | ||
| Q2 25 | $53.2M | $263.6M | ||
| Q1 25 | $24.2M | $44.1M | ||
| Q4 24 | $130.3M | $75.2M | ||
| Q3 24 | $242.0M | $188.4M | ||
| Q2 24 | $57.0M | $-95.6M | ||
| Q1 24 | $129.9M | $-308.6M |
| Q4 25 | $268.1M | $379.8M | ||
| Q3 25 | $286.4M | $354.5M | ||
| Q2 25 | $43.4M | $219.8M | ||
| Q1 25 | $14.8M | $-12.3M | ||
| Q4 24 | $114.5M | $-17.3M | ||
| Q3 24 | $237.0M | $54.7M | ||
| Q2 24 | $52.3M | $-205.5M | ||
| Q1 24 | $123.2M | $-465.1M |
| Q4 25 | 19.0% | 25.4% | ||
| Q3 25 | 20.5% | 25.1% | ||
| Q2 25 | 3.2% | 16.7% | ||
| Q1 25 | 1.1% | -1.1% | ||
| Q4 24 | 9.2% | -1.5% | ||
| Q3 24 | 20.3% | 5.5% | ||
| Q2 24 | 4.6% | -22.1% | ||
| Q1 24 | 10.6% | -61.9% |
| Q4 25 | 1.1% | 2.5% | ||
| Q3 25 | 0.6% | 3.4% | ||
| Q2 25 | 0.7% | 3.3% | ||
| Q1 25 | 0.7% | 5.0% | ||
| Q4 24 | 1.3% | 8.2% | ||
| Q3 24 | 0.4% | 13.3% | ||
| Q2 24 | 0.4% | 11.8% | ||
| Q1 24 | 0.6% | 20.8% |
| Q4 25 | 2.59× | 6.28× | ||
| Q3 25 | 2.76× | 3.22× | ||
| Q2 25 | 0.60× | 2.79× | ||
| Q1 25 | 0.33× | 34.71× | ||
| Q4 24 | 1.26× | — | ||
| Q3 24 | 1.77× | — | ||
| Q2 24 | 0.58× | — | ||
| Q1 24 | 1.12× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
